Contact

Category: narrows

  • Israeli gov’t mulls tax cuts as deficit narrows

    •

    Investor Empires

    The exceptional data published on Monday by the public accountant – a record number at all in the state’s revenues in January 2025 and narrowing the financial deficit faces the Ministry of Finance with a challenge. While the Ministry of Finance officials try to cool this enthusiasm, and to emphasize…

  • Israel’s fiscal deficit narrows after record state revenues

    •

    Investor Empires

    Israel’s financial deficit has decreased sharply from 6.9 % of GDP in the twelve months until the end of December 2024 to 5.8 %, or 115 billion New, in the twelve months until the end of January 2025. The improvement in the financial deficit follows a record number of 63.1…

  • Israel’s fiscal deficit narrows for second straight month

    •

    Investor Empires

    Israel’s fiscal deficit decreased for the second month in a row. Finance Ministry Accountant General Eli Rotenberg reported today that the deficit in the 12 months to the end of November this year amounted to 7.7% of GDP, or NIS 150 billion. In the 12 months to the end of…

  • Israel’s fiscal deficit narrows after 18 months of rises

    •

    Investor Empires

    The Israeli fiscal deficit has shrunk for the first time since the beginning of the war. Finance Ministry Accountant General Eli Rotenberg reported today that the deficit in the 12 months to the end of October this year amounted to 7.9% of GDP, or NIS 154 billion. In the 12…

  • Unga narrows full year loss to Sh669.5m on lower costs

    •

    Investor Empires

    Manufacturer Unga Group Plc narrowed its loss for the year ending June 2024 to Sh669.5 million from Sh959.3 million previously, on lower costs. The company attributed the lower costs to improved efficiencies in its operations and one-time gains in foreign exchange with the appreciation of the Kenyan shilling in the…

  • GSK slides 6% after US CDC narrows scope of RSV shots By Reuters

    •

    Investor Empires

    (Reuters) – GlaxoSmithKline shares fell more than 6% on Thursday, a day after the U.S. public health agency narrowed its recommendation for the use of all respiratory syncytial virus (RSV) vaccines and suspended recommending their use in people under 60. The US Centers for Disease Control and Prevention (CDC) said…

  • Teva loss narrows as revenue grows

    Teva loss narrows as revenue grows

    •

    bitlyfool

    With the recovery of the generic drug market in the United States Teva Pharmaceutical Industries Limited (New York Stock Exchange: Tifa; level: Tifa) It ended the first quarter of 2024 with revenues of $3.81 billion, an increase of 4.3% from the first quarter of 2023, and above analysts’ expectations of…